473 filings
10-Q
2019 Q3
GTBP
GT Biopharma Inc
Quarterly report
14 Nov 19
4:02pm
EFFECT
GTBP
GT Biopharma Inc
3 Oct 19
Notice of effectiveness
12:15am
CORRESP
GTBP
GT Biopharma Inc
26 Sep 19
Correspondence with SEC
12:00am
8-K
GTBP
GT Biopharma Inc
24 Sep 19
GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to Das Therapeutics
8:00am
UPLOAD
GTBP
GT Biopharma Inc
20 Sep 19
Letter from SEC
12:00am
8-K
nm0 fhswt9ikfv0wzco
23 Aug 19
Entry into a Material Definitive Agreement
5:14pm
4
vofj8 ccx
16 Aug 19
GT Biopharma / Tony Cataldo ownership change
4:57pm
4
ojk cf41y
16 Aug 19
GT Biopharma / Steven W Weldon ownership change
4:51pm
EFFECT
5eu9q34zqd08 nptynrv
15 Jul 19
Notice of effectiveness
12:15am
CORRESP
90wcn vlde7y6mzv
8 Jul 19
Correspondence with SEC
12:00am
UPLOAD
m02zqnb be0o
2 Jul 19
Letter from SEC
12:00am
8-K
x6cxg5i37g4s 4903fv
24 May 19
Entry into a Material Definitive Agreement
6:14am
8-K
6g1re325kv58 475
19 Apr 19
Unregistered Sales of Equity Securities
4:23pm
8-K
fc5kt11ov
5 Apr 19
Amendments to Articles of Incorporation or Bylaws
4:34pm